U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Development & Approval Process (CBER)
  4. 2025 Biological Device Application Approvals
  1. Development & Approval Process (CBER)

2025 Biological Device Application Approvals

This list reflects information regarding the applications as of the approval/clearance date. It is not updated with regard to applicant or application status changes. The applications are listed in order by date of approval / clearance.

2025 Biological Device Application Approvals
Tradename/Common NameDescription and Indication for DeviceSubmission IDManufacturerClearance Date
Adaptive Nomogram Bottle 
Empty container for the collection and processing of blood and blood components
For the collection, storage, and shipment of plasma prior to fractionation.BK251160/0Fresenius Kabi AG 
Three Corporate Drive
Lake Zurich, IL 60047
02/21/2025
Lookback Notification System version 2.0 
Blood establishment computer software and accessories
The Lookback Notification System is intended to generate and maintain electronic lookback records and allows for the automated creation, distribution and updating of applicable consignee notifications to assist in effectively identifying and removing unsuitable units (Source Plasma), prior to manufacturing.BK241136/0BioLife Plasma Services LP 
1200 Lakeside Drive 
Bannockburn, IL 60015
02/20/2025
Aurora Xi Plasmapheresis System Software Version 2.0
Automated Blood Cell Separator
The Aurora Xi Plasmapheresis System is intended for the automated collection of plasma by membrane filtration to be processed as Source Plasma. The Aurora Xi System is to be used with a single-use Plasmacell Xi Disposable Set and 4% sodium citrate anticoagulant and allows for Saline and No Saline Protocol options.BK241135/0Fresenius Kabi AG
Three Corporate Drive
Lake Zurich, IL 60047
01/24/2025
cobas pro serology solution (applicable to)
a) Elecsys Syphilis
b) Elecsys Anti-CMV 
Test, Syphilis, Treponema (FOR DONOR TESTING)
Syphilis Assay: Elecsys Syphilis is an in vitro immunoassay for the qualitative detection of total antibodies (IgG and IgM) to Treponema pallidum in human serum and plasma. Elecsys Syphilis is intended to screen individual human donors, including volunteer donors of whole blood and blood components. This test is also intended to be used to screen organ, tissue and cell donors, when donor samples are obtained while the donor’s heart is still beating. It is not intended for use on cord blood specimens.

The electrochemiluminescence immunoassay “ECLIA” is intended for use with the cobas pro serology solution equipped with cobas e 801 analytical unit.

Anti-CMV Assay: Elecsys Anti-CMV is an in vitro immunoassay for the qualitative detection of antibodies to Cytomegalovirus in human serum and plasma. Elecsys Anti-CMV is intended to screen individual human donors, including volunteer donors of whole blood, and blood components. This test is also intended to be used to screen organ, tissue and cell donors, when donor samples are obtained while the donor’s heart is still beating. It is not intended for use on cord blood specimens.

The electrochemiluminescence immunoassay “ECLIA” is intended with cobas pro serology solution equipped with the cobas e 801 analytical unit.

cobas pro serology solution: The cobas pro serology solution is a combination of the cobas pro serology controller, cobas pro integrated solutions (cobas e 801 analytical units only) and applicable licensed blood screening assays. The system automates electrochemiluminescence immunoassay test processing, result interpretation, and data management functions for screening of donations of whole blood and blood components using plasma or serum samples. The system is intended for use only with licensed blood screening assays in US donor screening laboratories and plasma fractionators. It is intended for use only by personnel who are trained in its operation. The cobas pro serology solution is intended to be used by trained laboratory technicians. Intended customers Intended customers of the cobas pro serology controller used in combination with cobas pro integrated solutions (cobas e 801 analytical units only) are donor screening and plasma fractionation companies in the United States.
BK241148/0Roche Diagnostics
9115 Hague Road
Indianapolis, IN 46250
01/10/2025
AHC Platelet Concentrate Separator 
Platelet and Plasma Separator for Bone Graft Handling
The AHC Platelet Concentrate Separator is designed to be used for preparation of autologous platelet rich plasma from a small sample of peripheral blood for mixing with autograft and/or allograft bone prior to application to a bony defect for improving handling characteristics.BK231018/0Sunphoria Co.,Ltd
12F-1, No. 51, Hengyang Rd,
Zhongzheng Dist.
Taipei City, 10045
Taiwan
01/10/2025
Galileo Echo 
Automated blood grouping and antibody test system
The Galileo Echo is a microprocessor-controlled instrument designed to fully automate immunohematology in vitro diagnostic testing of human blood. The Galileo Echo automates test processing, result interpretation and data management functions. The Galileo Echo is designed to automate standard immunohematology assays using a micro-well strip-based platform. Assays include ABO and Rh (D) typing, detection/identification of IgG red blood cell antibodies, compatibility testing and red blood cell phenotyping.

The Galileo Echo is a closed system intended for use only with the reagents described in the Galileo Echo Operator Manual, Regional Attachment - North America - Galileo Echo Assay Reagents and Cutoffs.

The Galileo Echo is for in vitro diagnostic use.
BK210608/0Immucor, Inc.
3130 Gateway Drive
Norcross, GA 30071
01/08/2025
Complement Control Cells 
Quality control kit for blood banking reagents
Complement Control Cells are intended for use in confirming reactivity of the anti-C3 component of Anti-Human Globulin.BK210604/0Immucor, Inc.
3130 Gateway Drive
Norcross, GA 30071
01/08/2025
Echo Lumena 
Automated blood grouping and antibody test system
The Echo Lumena is a microprocessor-controlled instrument designed to fully automate immunohematology in vitro diagnostic testing of human blood. The Echo Lumena automates test processing, result interpretation, and data management functions. The Echo Lumena is designed to automate standard immunohematology assays using a microwell strip-based platform. Assays include ABO and Rh (D) typing, detection/identification of IgG red blood cell antibodies, compatibility testing, and red blood cell phenotyping.

The Echo Lumena is a closed system intended for use only with the reagents described in the Echo Lumena Operator Manual, Regional Attachment - North America - Echo Lumena Assay Reagents and Cutoffs.

The Echo Lumena is for in vitro diagnostic use.
BK210601/0Immucor, Inc.
3130 Gateway Drive
Norcross, GA 30071
01/08/2025
MatchX
Test, Qualitative, for HLA, Non-Diagnostic
MatchX is an optional accessory to the following LIFECODES antibody detection kits and LIFECODES HLA-SSO Typing Kit for use with Luminex:

LIFECODES LifeScreen Deluxe 628215 LIFECODES LifeScreen XP 628220 LIFECODES Class I ID 628200 LIFECODES Class II ID v2 628223 LIFECODES LSA Class I 265100IVD LIFECODES LSA Class II 265200IVD LIFECODES HLA-A eRES SSO Typing Kit 628913 LIFECODES HLA-B eRES SSO Typing Kit 628917 LIFECODES HLA-C eRES SSO Typing Kit 628921 LIFECODES HLA-DRB1 eRES SSO Typing Kit 628925

LIFECODES HLA-DRB 345 SSO Typing Kit 628927 LIFECODES HLA-DQA1/B1 SSO Typing Kit 628930 LIFECODES HLA-DPA1/B1 SSO Typing Kit 628936

Default settings for all assays are aligned with the IFU and the performance characteristics of the assay. Any other methods of assignment would need to be validated by lab personal prior to use.

The software is intended for In Vitro Diagnostic (IVD) use.
BK241067/0Immucor GTI Diagnostics, Inc.
20925 Crossroads Circle
Waukesha, WI 53186
01/02/2025
Back to Top